---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-169651"
form_type: "8-K"
ticker: null
cik: "0001800682"
company_name: "Cano Health, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:35:24.069446+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cano Health CEO Marlow Hernandez resigns; Mark Kent appointed Interim CEO

## Summary
- CEO Marlow Hernandez resigned effective June 16, 2023; remains on Board.
- Mark Kent, current Chief Strategy Officer, appointed Interim CEO effective immediately.
- Kent receives $475k base salary, $325k target cash incentive, $1.5M annual equity, $1.5M RSUs vesting June 2024.
- Board will conduct external search for permanent CEO and refresh Board with new independent directors.

## SEC filing metadata
- accession: 0001193125-23-169651
- form_type: 8-K
- cik: 0001800682
- company_name: Cano Health, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/d512837d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-169651
- JSON: https://secwatch.observer/filing/0001193125-23-169651.json
- Plain text: https://secwatch.observer/filing/0001193125-23-169651.txt

## Key facts
- Executive change
  Mark Kent was appointed as Interim Chief Executive Officer at Cano Health, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Effective immediately, on June 16, 2023, the Board of Directors (the “ Board ”) of Cano Health, Inc. (the “ Company ”) elected the Company’s current Chief Strategy Officer, Mr. deMarquette (“ Mark ”) Kent, as the Company’s Interim Chief Executive Officer (the “ Interim CEO ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm
- Executive change
  Marlow Hernandez resigned as Chief Executive Officer at Cano Health, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Mr. Kent will replace Dr. Marlow Hernandez, who tendered his resignation as the Company’s Chief Executive Officer, as well as all positions he holds at the Company’s subsidiaries, effective immediately on June 16, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.